Genealogy v1 Consistency Check Report

Checks run against the canonical node and edge registers before visual rendering. The purpose is to prevent the graph from encoding stronger claims than the evidence.

1. Referential integrity

  • Nodes: 59
  • Edges: 64
  • Missing node references: 0

2. Causal-jump check

  • Potential illicit causal jumps detected: 0
  • Rule: mechanism/construct nodes should not directly establish distal clinical outcomes unless the edge is explicitly hypothesis/open-gate or supported by an intervention outcome study.
  • PASS: no mechanism/construct → distal-outcome edge is encoded as a moderate/high-confidence causal support claim.

3. Population-jump check

  • Potential population jumps detected: 0
  • Rule: child, healthy-adult, symptom-stratified, clinical, and forensic populations may be historically connected but cannot silently inherit efficacy claims from one another.
  • PASS: no mismatched/transfer population edge carries moderate/high-confidence direct support/change language.

4. Endpoint-jump check

  • Potential physiological/proximal → distal endpoint jumps detected: 0
  • Rule: skin conductance, HRV/LF-HF, gaze, attention, and recognition changes are not silently promoted into CU, aggression, ASPD, or other distal outcomes.
  • PASS: no physiological/proximal node directly establishes a distal trait/symptom outcome.

5. Explicit open gates retained

  • Brain stimulation → APD/ASPD symptom reduction: OPEN.
  • HRV biofeedback → CU-trait reduction: OPEN.
  • Fanti-specific VR intervention → composite empathy/aggression/anxiety/depression outcomes: OPEN.
  • Heterogeneity/biomarkers → prospective treatment matching: OPEN.
  • Parent-child sadness-process change → distal CU/conduct/aggression change: OPEN by omission; no such edge is encoded.

6. Constraint branches retained

  • 2019 meta-analysis constrains a universal psychophysiological biomarker account.
  • 2020/2024 attention studies constrain a simple eye-neglect → emotion-recognition account.
  • 2025 cTBS+AMT constrains additive symptom efficacy of active cTBS for anxiety.
  • 2016 neurocognitive results constrain the idea that all candidate mechanisms are CU-subtype-specific.

Result

Genealogy v1 substrate is safe to render. No visual edge should bypass the explicit open gates above.

Built with LogoFlowershow